Abstract is: Glycogen synthase kinase-3 beta, (GSK-3 beta), is an enzyme that in humans is encoded by the GSK3B gene. In mice, the enzyme is encoded by the Gsk3b gene. Abnormal regulation and expression of GSK-3 beta is associated with an increased susceptibility towards bipolar disorder.
| P1057 | chromosome | human chromosome 3 | Q668633 |
| P4196 | cytogenetic location | 3q13.33 | |
| P688 | encodes | glycogen synthase kinase 3 beta | Q5514576 |
| P5572 | expressed in | Achilles tendon | Q223172 |
| postcentral gyrus | Q956517 | ||
| ganglionic eminence | Q4133185 | ||
| sural nerve | Q6135922 | ||
| ventricular zone | Q28455175 | ||
| right testis | Q66502829 | ||
| left testis | Q66502830 | ||
| skin of thigh | Q66527052 | ||
| epithelium of colon | Q66714209 | ||
| buccal mucosa cell | Q116529247 | ||
| P703 | found in taxon | Homo sapiens | Q15978631 |
| P645 | genomic end | 119813264 | |
| 120094994 | |||
| P644 | genomic start | 119540170 | |
| 119821321 | |||
| P684 | ortholog | Gsk3b | Q21518808 |
| Gsk3b | Q24383785 | ||
| gsk-3 | Q29685492 | ||
| gsk3ba | Q29772805 | ||
| P2548 | strand orientation | reverse strand | Q22809711 |
FileName: Protein GSK3B PDB 1gng.png
Description: Structure of the GSK3B protein. Based on PyMOL rendering of PDB 1gng.
Artist: Emw
Work is copyrighted.
License: CC BY-SA 3.0
Attribution is required.
FileName: PBB GE GSK3B 209945 s at fs.png
Description: Gene expression pattern of the GSK3B gene.
Artist: AndrewGNF at English Wikipedia
Work is copyrighted.
License: CC BY-SA 3.0
Attribution is required.
| Q27594437 | hsa-let-7a-3p |
| Q27594441 | hsa-let-7b-3p |
| Q27595112 | hsa-let-7f-1-3p |
| Q27595232 | hsa-let-7f-2-3p |
| Q27593451 | hsa-miR-1185-1-3p |
| Q27593452 | hsa-miR-1185-2-3p |
| Q27595273 | hsa-miR-1277-5p |
| Q27593313 | hsa-miR-1297 |
| Q27594358 | hsa-miR-155-5p |
| Q27593307 | hsa-miR-15a-5p |
| Q27594548 | hsa-miR-15b-5p |
| Q27593305 | hsa-miR-16-5p |
| Q27594926 | hsa-miR-182-5p |
| Q27594930 | hsa-miR-183-5p |
| Q27593552 | hsa-miR-190a-3p |
| Q27593679 | hsa-miR-1910-5p |
| Q27593706 | hsa-miR-195-5p |
| Q27592872 | hsa-miR-199a-5p |
| Q27593222 | hsa-miR-26a-5p |
| Q27592900 | hsa-miR-29b-3p |
| Q27593850 | hsa-miR-3065-3p |
| Q27594429 | hsa-miR-33a-3p |
| Q27592984 | hsa-miR-346 |
| Q27594234 | hsa-miR-3606-3p |
| Q27593489 | hsa-miR-369-3p |
| Q27595249 | hsa-miR-374a-5p |
| Q27595242 | hsa-miR-374b-5p |
| Q27593480 | hsa-miR-377-3p |
| Q27594972 | hsa-miR-383-3p |
| Q27593484 | hsa-miR-409-3p |
| Q27593483 | hsa-miR-409-5p |
| Q27593490 | hsa-miR-410-3p |
| Q27594482 | hsa-miR-425-5p |
| Q27594836 | hsa-miR-4465 |
| Q27594822 | hsa-miR-4643 |
| Q27594557 | hsa-miR-4789-5p |
| Q27593907 | hsa-miR-5011-5p |
| Q27595318 | hsa-miR-513a-3p |
| Q27595314 | hsa-miR-513c-3p |
| Q27593229 | hsa-miR-548c-3p |
| Q27594762 | hsa-miR-5683 |
| Q27594372 | hsa-miR-5692b |
| Q27594709 | hsa-miR-5692c |
| Q27592723 | hsa-miR-5697 |
| Q27594533 | hsa-miR-6083 |
| Q27593862 | hsa-miR-6787-3p |
| Q27594500 | hsa-miR-8064 |
| Q27594154 | hsa-miR-8485 |
| Q27594769 | hsa-miR-877-3p |
| Q27593334 | hsa-miR-92a-3p |
| Q27594928 | hsa-miR-96-5p |
| Q27595231 | hsa-miR-98-3p |
| Q84972217 | Acute viral myocarditis |
| Q109861301 | Alzheimer's disease |
| Q29892262 | Alzheimer's disease and miRNA effects |
| Q30225359 | Androgen receptor signaling pathway |
| Q30225526 | Angiopoietin-like protein 8 regulatory pathway |
| Q30225495 | B cell receptor signaling pathway |
| Q30225496 | Brain-derived neurotrophic factor (BDNF) signaling pathway |
| Q54991093 | Breast cancer pathway |
| Q30151248 | Cardiac hypertrophic response |
| Q30102240 | Cardiac progenitor differentiation |
| Q29892200 | Cell cycle |
| Q30225529 | Chemokine signaling pathway |
| Q50400050 | Chromosomal and microsatellite instability in colorectal cancer |
| Q30230834 | Circadian rhythm genes |
| Q30151296 | Copper homeostasis |
| Q30225489 | Corticotropin-releasing hormone signaling pathway |
| Q30231006 | DNA damage response (only ATM dependent) |
| Q102733920 | EGFR tyrosine kinase inhibitor resistance |
| Q30225532 | Embryonic stem cell pluripotency pathways |
| Q54989421 | Epithelial to mesenchymal transition in colorectal cancer |
| Q30230897 | ErbB signaling pathway |
| Q30225425 | Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling |
| Q30151288 | Focal adhesion |
| Q30230865 | Focal adhesion: PI3K-Akt-mTOR-signaling pathway |
| Q72082709 | Gastrin signaling pathway |
| Q30230918 | Glycogen synthesis and degradation |
| Q30225473 | IL-17 signaling pathway |
| Q102744190 | IL-18 signaling pathway |
| Q30225358 | IL-5 signaling pathway |
| Q30225404 | IL-6 signaling pathway |
| Q30225470 | IL-7 signaling pathway |
| Q102716977 | Influence of laminopathies on Wnt signaling |
| Q30225566 | Insulin signaling |
| Q30225466 | Leptin signaling pathway |
| Q102719481 | MAP3K1 role in promoting and blocking gonadal determination |
| Q109861217 | Malignant pleural mesothelioma |
| Q30225381 | MicroRNAs in cardiomyocyte hypertrophy |
| Q30230780 | Microtubule cytoskeleton regulation |
| Q59829224 | NRF2-ARE regulation |
| Q29891995 | Neural crest differentiation |
| Q74069909 | Nonalcoholic fatty liver disease |
| Q61996544 | Notch signaling pathway (Netpath) |
| Q104857857 | Overlap between signal transduction pathways contributing to LMNA laminopathies |
| Q30225421 | PI3K-AKT-mTOR signaling pathway and therapeutic opportunities |
| Q50400941 | PI3K-Akt signaling pathway |
| Q50400139 | PI3K/AKT/mTOR - VitD3 signaling |
| Q30225419 | Physico-chemical features and toxicity-associated pathways |
| Q30225469 | Prolactin signaling pathway |
| Q30225412 | Regulation of Wnt / B-catenin signaling by small molecule compounds |
| Q30230738 | Regulation of apoptosis by parathyroid hormone-related protein |
| Q30230984 | Senescence and autophagy in cancer |
| Q62059922 | Synaptic signaling pathways associated with autism spectrum disorder |
| Q30225515 | T cell receptor and co-stimulatory signaling |
| Q107363266 | T-cell activation SARS-CoV-2 |
| Q30225430 | T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
| Q30225468 | TNF-related weak inducer of apoptosis (TWEAK) signaling pathway |
| Q102742382 | Thyroid hormones production and peripheral downstream signaling effects |
| Q30225525 | VEGFA-VEGFR2 signaling pathway |
| Q30225555 | Wnt signaling |
| Q30225399 | Wnt signaling pathway |
| Q30225546 | Wnt signaling pathway and pluripotency |
| Q30225410 | Wnt/beta-catenin signaling pathway in leukemia |
| Q44013044 | endometrial cancer |
| Q30225378 | energy metabolism |
| Q54989478 | lncRNA in canonical Wnt signaling and colorectal cancer |
| Q28922670 | melatonin metabolism and effects |
| Q44017754 | miRNA regulation of prostate cancer signaling pathways |
| Q56856314 | ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
| Q5514576 | glycogen synthase kinase 3 beta | encoded by | P702 |
| Q115212924 | Metabolic Contributions of Wnt Signaling: More Than Controlling Flight | main subject | P921 |
| cy | GSK3B | wikipedia |
| Glycogen synthase kinase-3 beta | wikipedia | |
| Kinaza glikogen sintaze-3 beta | wikipedia | |
| GSK-3β | wikipedia | |
| GSK3B | wikipedia | |
| GSK3B | wikipedia | |
| Tatar language (tt / Q25285) | GSK3B | wikipedia |
| GSK3B | wikipedia |
Search more.